Invention Grant
US08454947B1 PEG-interferon lambda 1 conjugates 有权
PEG-干扰素λ1缀合物

PEG-interferon lambda 1 conjugates
Abstract:
The present application discloses new PEG-interferon lambda 1 conjugates (PEG-IFNλ1), processes for their preparation, pharmaceutical compositions containing these conjugates and processes for making the same. These conjugates have increased blood half-lives and persistence time compared to IFNλ1 and are effective in the treatment of hepatitis B and hepatitis C.
Information query
Patent Agency Ranking
0/0